Asarfi Hospital logo

Asarfi Hospital financials and balance sheet

BSE: 543943Healthcare ServicesSmall Cap

Last close ₹170.10down ₹9.40 (5.24%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹179.50.

52-week range of traded prices to 23 Oct 2026
₹135.00Low, 6 Nov 2025₹256.95High, 7 May 2026
Market cap
₹335 Cr2,017th largest listed
P/E
20.1
P/B
3.4
Dividend yield
Nonein the last 12 months
ROE
18.7%
Debt to equity
0.59
Volume, BSE
27,000

3 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Asarfi Hospital annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹174 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue174
  2. Materials and goods−39
  3. Employee costs−26
  4. Other expenses−73
  5. Operating profit35
  6. Depreciation−12
  7. Other income+2.7
  8. Finance costs−4.2
  9. Profit before tax22
  10. Tax−5.5
  11. Net profit17

What the company owns

  • Plant, investments and other assets₹123 Cr
  • Receivables₹54 Cr
  • Cash and bank₹13 Cr
  • Inventory₹3 Cr

What pays for it: net worth and liabilities

  • Net worth₹98 Cr
  • Borrowings₹58 Cr
  • Other liabilities₹21 Cr
  • Owed to suppliers₹17 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Asarfi Hospital half-yearly results

₹ croreMar 2024Filed 27 JulMar 2025Filed 8 MayMar 2026Filed 11 May
Revenue from operations84121174
6897138
Materials and goods bought202839
Employee costs141926
Other expenses345173
Operating profit before depreciation162435
Operating margin19.0%19.5%20.3%
Materials, % of revenue24.1%23.1%22.4%
Employee costs, % of revenue16.7%15.5%15.3%
Other expenses, % of revenue40.2%41.9%42.0%
Depreciation and amortisation91312
Operating profit after depreciation71124
Other income283
Finance costs344
One-off items0––
Profit before tax61422
246
Net profit41117
Net margin4.9%8.8%9.6%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2024Filed 27 JulMar 2025Filed 8 MayMar 2026Filed 11 May
708198
Share capital202020
Reserves516178
324958
414149
424246
Total assets154164193
107105122
475871
Net debt144745
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2024Filed 27 JulMar 2025Filed 8 MayMar 2026Filed 11 May
26.1−4.318.3
27.0−1.324.9
9.2−27.8−13.1
Receivables–−15.5−14.3
Inventories–−0.5−0.9
Payables–−12.03.8
Other working capital–0.2−1.7
Tax paid−0.2−3.1−5.6
Interest paid0.00.0−1.1
Capital spending46.111.818.1
Free cash flow−20.0−16.10.2
−63.1−7.4−18.3
36.412.64.8
Dividends paid0.00.00.0
Shares bought back0.0––
Shares issued23.10.00.0
Net change in cash−0.60.84.8
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2024Filed 27 JulMar 2025Filed 8 MayMar 2026Filed 11 May
Earnings per share–₹5.37₹8.47
Diluted earnings per share–₹5.37₹8.47
Book value per share₹35.78₹41.16₹49.62
Shareholder yield−18.0%0.0%0.0%
Market cap at the year end (₹ crore)129163334
Earnings per share is left blank for the year to Mar 2024: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Consolidated, years to March.Asarfi Hospital PE ratio and valuation

RatioMar 2024Filed 27 JulMar 2025Filed 8 MayMar 2026Filed 11 May
Revenue growth–42.8%43.9%
Operating profit growth–46.7%49.8%
Net profit growth–154.1%57.5%
Earnings per share growth––57.7%
5.9%14.0%18.7%
–8.1 pts4.7 pts
From the net margin–4.6 pts1.3 pts
From asset turnover–4.0 pts4.3 pts
From borrowing–−0.6 pts−0.9 pts
Return on capital employed7.1%8.4%15.3%
Cash conversion626.5%−41.1%109.9%
Interest cover2.72.75.6
Debt to equity0.450.600.59
Receivable days105120114
Inventory days323030
Payable days446171156
Cash conversion cycle, days−309−20−12
Working capital days−39367
Asset turnover0.550.760.97
Assets per rupee of net worth2.192.102.00
Sales per rupee of plant0.901.191.60
Capital spending to depreciation5.240.931.57

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
9.3%
Cash from operations against operating profit
51.9%
Measure3 years
Return on equity, average12.8%
Return on capital employed, average10.3%
Operating margin, average19.6%
Net margin, average7.8%
Asset turnover, average0.76
Cash conversion cycle, days, average−114
Interest cover, average3.7
Debt to equity, average0.55

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations40.018.3
Cash from investing−88.8−18.3
Cash from financing53.74.8
Capital spending76.018.1
Dividends paid0.00.0
Shares issued for cash23.10.0
Borrowings raised–17.6
Borrowings repaid–8.6

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Altman Z-scorePublished threshold 1.812.16––
Receivables growth less revenue growthOur threshold 0 percentage points–21.21−7.91
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−10.612.08
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–12.38−8.06
Effective tax ratePublished threshold 17.16 per cent33.3226.1024.93
Tax charged less tax paid, % of profitOur threshold 10 percentage points30.534.57−0.14
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
7 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BBBRating UpgradedStable0.10
7 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesShort-term scaleCrisil A3+Rating Assigned2
7 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BBBRating UpgradedStable12.65
7 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BBBRating UpgradedStable28.50
7 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BBBRating UpgradedStable5.25
7 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BBBRating UpgradedStable11.50
26 Sep 2025CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanLong-term scaleCARE BB+; ISSUER NOT COOPERATING*Review, Re-affirmRating moved to ISSUER NOT COOPERATING categoryStable65.20
26 Sep 2025CARE Ratings Limited (opens in a new tab)Fund-based - LT-Cash CreditLong-term scaleCARE BB+; ISSUER NOT COOPERATING*Review, Re-affirmRating moved to ISSUER NOT COOPERATING categoryStable14.80
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.